Mice With Cardiac Overexpression of Peroxisome Proliferator–Activated Receptor (cid:1) Have Impaired Repolarization and Spontaneous Fatal Ventricular Arrhythmias
暂无分享,去创建一个
T. Shiomi | J. D’Armiento | C. Vásquez | G. Morley | S. Marx | A. Katchman | Chad M. Trent | J. Morrow | Joshua M Lader | R. Khan | Haiyan Huang | Shunichi Homma | Ira J. Goldberg | Vaibhav Amin | N. Son
[1] J. Pankow,et al. Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study , 2010, Acta Diabetologica.
[2] Rita Ouellet-Hellstrom,et al. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. , 2010, JAMA.
[3] Nan-Hung Pan,et al. Oxidative stress and inflammation modulate peroxisome proliferator‐activated receptors with regional discrepancy in diabetic heart , 2010, European journal of clinical investigation.
[4] J. Witteman,et al. Serum glucose and insulin are associated with QTc and RR intervals in nondiabetic elderly. , 2010, European journal of endocrinology.
[5] M. Kawai,et al. Heart rate-corrected QT interval in resting ECG predicts the risk for development of type-2 diabetes mellitus , 2010, European Journal of Epidemiology.
[6] Yibo Wang,et al. Patients with Metabolic Syndrome Have Prolonged Corrected QT Interval (QTc) , 2009, Clinical cardiology.
[7] G. Paolisso,et al. Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome[S] , 2009, Journal of Lipid Research.
[8] B. Baird,et al. Effect of Pioglitazone on Survival and Renal Function in a Mouse Model of Polycystic Kidney Disease , 2009, American Journal of Nephrology.
[9] S. Marx,et al. Protein kinase C isoforms differentially phosphorylate Ca(v)1.2 alpha(1c). , 2009, Biochemistry.
[10] W. Krek,et al. Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. , 2009, Cell metabolism.
[11] J. Stypmann,et al. Echocardiographic assessment of global left ventricular function in mice , 2009, Laboratory animals.
[12] C. R. Wilson,et al. Adaptation and Maladaptation of the Heart in Obesity , 2008, Hypertension.
[13] J. Nerbonne,et al. PPARalpha-mediated remodeling of repolarizing voltage-gated K+ (Kv) channels in a mouse model of metabolic cardiomyopathy. , 2008, Journal of molecular and cellular cardiology.
[14] G. Mazzaglia,et al. Out of hospital sudden cardiac death in Italy: a population-based case–control study , 2008, Journal of cardiovascular medicine.
[15] Gregory S. Harris,et al. PPAR-γ expression in animals subjected to volume overload and chronic Urotensin II administration , 2008, Peptides.
[16] G. Fishman,et al. Electrical remodeling contributes to complex tachyarrhythmias in connexin43‐deficient mouse hearts , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] Michael D. Schneider,et al. Abnormal Conduction and Morphology in the Atrioventricular Node of Mice With Atrioventricular Canal–Targeted Deletion of Alk3/Bmpr1a Receptor , 2007, Circulation.
[18] C. Glass,et al. Anti-inflammatory and antidiabetic roles of PPARgamma. , 2007, Novartis Foundation symposium.
[19] L. Orci,et al. Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. , 2007, Circulation research.
[20] E. Abel,et al. Diabetic cardiomyopathy revisited. , 2007, Circulation.
[21] T. O’Connell,et al. Isolation and culture of adult mouse cardiac myocytes. , 2007, Methods in molecular biology.
[22] A. Moss,et al. Obesity As a Risk Factor for Sustained Ventricular Tachyarrhythmias in MADIT II Patients , 2007, Journal of cardiovascular electrophysiology.
[23] Guy Salama,et al. Mouse models of long QT syndrome , 2007, The Journal of physiology.
[24] M. Russell,et al. Cardiomyocyte-Specific Knockout and Agonist of Peroxisome Proliferator–Activated Receptor-γ Both Induce Cardiac Hypertrophy in Mice , 2005, Circulation research.
[25] S. Homma,et al. Peroxisome Proliferator-Activated Receptor Agonists Modulate Heart Function in Transgenic Mice with Lipotoxic Cardiomyopathy , 2005, Journal of Pharmacology and Experimental Therapeutics.
[26] Xianlin Han,et al. Transgenic Expression of Fatty Acid Transport Protein 1 in the Heart Causes Lipotoxic Cardiomyopathy , 2005, Circulation research.
[27] G. Fishman,et al. Modulation of Cardiac Gap Junction Expression and Arrhythmic Susceptibility , 2004, Circulation research.
[28] G. Breithardt,et al. Phytanic Acid Accumulation Is Associated with Conduction Delay and Sudden Cardiac Death in Sterol Carrier Protein‐2/Sterol Carrier Protein‐x Deficient Mice , 2004, Journal of cardiovascular electrophysiology.
[29] G. Noon,et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] J. Nerbonne,et al. Heterogeneous expression of repolarizing, voltage‐gated K+ currents in adult mouse ventricles , 2004, The Journal of physiology.
[31] Tobias Opthof,et al. Slow Conduction and Enhanced Anisotropy Increase the Propensity for Ventricular Tachyarrhythmias in Adult Mice With Induced Deletion of Connexin43 , 2004, Circulation.
[32] JoAnn E. Manson,et al. Prospective Study of Sudden Cardiac Death Among Women in the United States , 2003, Circulation.
[33] M R Franz,et al. Monophasic Action Potential Recordings from Intact Mouse Heart: Validation, Regional Heterogeneity, and Relation to Refractoriness , 2001, Journal of cardiovascular electrophysiology.
[34] V. Shusterman,et al. Targeted Replacement of Kv1.5 in the Mouse Leads to Loss of the 4-Aminopyridine-Sensitive Component of IK,slow and Resistance to Drug-Induced QT Prolongation , 2001, Circulation research.
[35] G. Duker,et al. Instability and Triangulation of the Action Potential Predict Serious Proarrhythmia, but Action Potential Duration Prolongation Is Antiarrhythmic , 2001, Circulation.
[36] Michael D. Schneider,et al. Conduction Slowing and Sudden Arrhythmic Death in Mice With Cardiac-Restricted Inactivation of Connexin43 , 2001, Circulation research.
[37] N. Weissman,et al. Remodelling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin , 2000, The Journal of physiology.
[38] X. Jouven,et al. Diabetes as a risk factor for sudden death , 1999, The Lancet.
[39] J. Nerbonne,et al. Molecular basis of transient outward K+ current diversity in mouse ventricular myocytes , 1999, The Journal of physiology.
[40] J. Nerbonne,et al. Attenuation of the slow component of delayed rectification, action potential prolongation, and triggered activity in mice expressing a dominant-negative Kv2 alpha subunit. , 1999, Circulation research.
[41] M Delmar,et al. Characterization of Conduction in the Ventricles of Normal and Heterozygous Cx43 Knockout Mice Using Optical Mapping , 1999, Journal of cardiovascular electrophysiology.
[42] Weinong Guo,et al. Four Kinetically Distinct Depolarization-activated K+ Currents in Adult Mouse Ventricular Myocytes , 1999, The Journal of general physiology.
[43] P Ducimetière,et al. Predicting sudden death in the population: the Paris Prospective Study I. , 1999, Circulation.
[44] G. Paolisso,et al. Association of fasting plasma free fatty acid concentration and frequency of ventricular premature complexes in nonischemic non-insulin-dependent diabetic patients. , 1997, The American journal of cardiology.
[45] B. Sakmann,et al. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches , 1981, Pflügers Archiv.
[46] C. Chi,et al. PPAR(gamma)/PGC-1(alpha) pathway in E-cadherin expression and motility of HepG2 cells. , 2009, Anticancer research.
[47] J. Nerbonne,et al. Kv4.3 is not required for the generation of functional Ito,f channels in adult mouse ventricles. , 2008, Journal of molecular and cellular cardiology.
[48] S. Homma,et al. Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice. , 2007, The Journal of clinical investigation.
[49] D. Gómez-Garre,et al. Activation of peroxisome proliferator-activated receptor-alpha and -gamma in auricular tissue from heart failure patients. , 2006, European journal of heart failure.
[50] A. Chawla,et al. Role of PPARgamma in macrophage biology and atherosclerosis. , 2004, Trends in endocrinology and metabolism: TEM.
[51] W. Koenig,et al. Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease. , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[52] Xianlin Han,et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. , 2002, The Journal of clinical investigation.